DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Arcturus Therapeutics Q4 EPS $(0.76) Down From $(0.1) YoY

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.76) per share. This is a 660 percent decrease over losses of $(0.1) per share from the same period last year.

Benzinga · 03/11/2020 20:02

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.76) per share. This is a 660 percent decrease over losses of $(0.1) per share from the same period last year.